Re: Comparison of Tamsulosin plus Serenoa repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study.
作者信息
Kaplan Steven A
出版信息
J Urol. 2016 Aug;196(2):503. doi: 10.1016/j.juro.2016.05.021. Epub 2016 May 11.
PMID:27479407
Abstract
摘要
相似文献
1
Re: Comparison of Tamsulosin plus Serenoa repens with Tamsulosin in the Treatment of Benign Prostatic Hyperplasia in Korean Men: 1-Year Randomized Open Label Study.
J Urol. 2016 Aug;196(2):503. doi: 10.1016/j.juro.2016.05.021. Epub 2016 May 11.
2
A prospective study of the efficacy of Serenoa repens, tamsulosin, and Serenoa repens plus tamsulosin treatment for patients with benign prostate hyperplasia.
Int Urol Nephrol. 2007;39(3):879-86. doi: 10.1007/s11255-006-9106-5. Epub 2007 Jan 4.
3
A Prospective, Open-Label Comparison of Tamsulosin plus Serenoa repens and Bovine Colostrum versus Tamsulosin Alone in the Treatment of Benign Prostatic Hyperplasia.
Urol Int. 2020;104(5-6):351-355. doi: 10.1159/000503735. Epub 2019 Dec 5.
4
[Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study].
Prog Urol. 2002 Jun;12(3):384-92; discussion 394-4.
5
Effects of hexanic extract of Serenoa repens (Permixon® 160 mg) on inflammation biomarkers in the treatment of lower urinary tract symptoms related to benign prostatic hyperplasia.
Prostate. 2015 Dec;75(16):1857-67. doi: 10.1002/pros.23059. Epub 2015 Aug 26.
6
Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study.
Eur Urol. 2002 May;41(5):497-506; discussion 506-7.
7
[Tamsulosin with or without Serenoa repens in benign prostatic hyperplasia: the OCOS trial].
Prog Urol. 2002 Jun;12(3):395-403; discussion 404.
8
Serenoa repens for benign prostatic hyperplasia.
Cochrane Database Syst Rev. 2002(3):CD001423. doi: 10.1002/14651858.CD001423.
9
10
Is Effective in the Treatment of Benign Prostatic Hyperplasia?
Am J Mens Health. 2020 May-Jun;14(3):1557988320936897. doi: 10.1177/1557988320936897.
引用本文的文献
1
Comparison of With Tamsulosin in the Treatment of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.
Am J Mens Health. 2020 Mar-Apr;14(2):1557988320905407. doi: 10.1177/1557988320905407.
2
Effect of α-receptor blockers on lower urinary tract symptoms, sexual function and quality of life in young and middle-aged men with benign prostatic hyperplasia.
Exp Ther Med. 2017 Jul;14(1):587-592. doi: 10.3892/etm.2017.4518. Epub 2017 May 29.
Zotero 插件